A 16-amino-acid peptide encoded not in nuclear DNA but within the mitochondrial 12S rRNA gene — one of a small class of mitochondrial-derived peptides. It appears to act as a mitochondrial-to-nuclear signal, inhibiting the folate-methionine cycle, raising AICAR, and activating AMPK, with downstream effects on glucose utilisation and metabolic adaptation. It translocates to the nucleus under metabolic stress and influences gene expression.
Genuinely interesting biology with real academic backing. Rodent studies report improved insulin sensitivity and exercise capacity, and levels decline with age in humans. Human interventional trials are essentially absent — the human data are observational associations, not evidence that administration produces benefit.
Not FDA-approved.
No meaningful human safety data. Long-term consequences of exogenous administration are unknown.
Forge Bioenergy does not publish dosing, reconstitution, or administration protocols for any peptide. See our editorial policy for why. If you are considering any substance on this page, that conversation belongs with a licensed physician.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.